Since May 2012, the JCI has aired twenty-six interviews with twenty-eight notable scientists for the series Conversations with Giants in Medicine. In the highlight reel to accompany the October 2014 issue, we’ve chosen some of the most memorable vignettes from the Conversations — stories that give life to the life sciences.
For the last five years, the JCI has had the privilege of working with the Albert and Mary Lasker Foundation to write profiles on the prizewinners. Coverage of the 2014 laureates will be featured in the October issue. In addition to the news features on the prizes, we have had the pleasure of interviewing several of the previous years’ laureates for the series “Conversations with Giants in Medicine.”
Napoleone Ferrara, of the University of California, San Diego, is best known for isolating and cloning vascular endothelial growth factor (VEGF). He then built the humanized monoclonal antibody against VEGF that led to the blockbuster drugs Avastin (for treating cancer) and Lucentis (for treating wet age-related macular degeneration).
Tony Fauci is the Director of the National Institute of Allergy and Infectious Diseases within the NIH. His work on HIV is at the forefront of infectious disease research, and he is the leader of the national discussion of infectious disease pandemics — the science behind them, the economy, the policy, and the politics that are also intertwined with them.
The biochemist P. Roy Vagelos is best known for leading Merck for 20 years, first as President of research and then later as CEO and Chairman of the Board. In his time at Merck, he revolutionized the way the company approached drug discovery, introduced the first statins to market, and organized the donation of ivermectin, the agent for control of river blindness, to any and all who need it for as long as it is needed.